Literature DB >> 11980933

Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection.

Judith Bruchfeld1, Getachew Aderaye, Ingela Berggren Palme, Bjarne Bjorvatn, Solomon Ghebremichael, Sven Hoffner, Lars Lindquist.   

Abstract

We have analyzed the molecular epidemiology and drug resistance of 121 Mycobacterium tuberculosis isolates from consecutive patients with culture-positive pulmonary tuberculosis attending a university hospital outpatient department in Addis Ababa, Ethiopia. Restriction fragment length polymorphism analysis and spoligotyping were used to analyze the DNA fingerprinting patterns. Fifty-one (41.2%) of the isolates were found in 13 clusters with two or more identical DNA patterns. Two such clusters contained 49.0% of all clustered isolates. In a multivariate logistic regression model, human immunodeficiency virus (HIV)-positive serostatus was significantly associated with clustering of isolates for patients of both sexes (odds ratio [OR], 2.55; 95% confidence interval [CI], 1.17 to 5.80). There was a trend toward increased clustering of isolates from tuberculous women residing in Addis Ababa (OR, 2.10; 95% CI, 0.85 to 5.25). In total, 17 of 121 isolates (14.0%) were resistant to one or more of the antituberculosis drugs isoniazid (8.3%), streptomycin (7.4%), rifampin (2.5%), and ethambutol (1.7%). The high rate of drug-resistant isolates (29.6%) coincided with the peak prevalence of HIV infection (77.8%) in patients 35 to 44 years old. The majority (62.5%) of resistant isolates in this group were found within clusters. The simultaneous accumulation of certain bacterial clones in a patient population likely reflects recent transmission. Hence, we conclude that tuberculosis is commonly caused by recent infection with M. tuberculosis in HIV-positive Ethiopian patients. Furthermore, with the rapidly increasing prevalence of HIV infection in Ethiopia, the burden of tuberculosis, including drug-resistant tuberculosis, is likely to increase. Strengthening of classical tuberculosis control measures by promoting active case finding among HIV-positive adults with tuberculosis is warranted to reduce rates of transmission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980933      PMCID: PMC130945          DOI: 10.1128/JCM.40.5.1636-1643.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients.

Authors:  S Lockman; J D Sheppard; C R Braden; M J Mwasekaga; C L Woodley; T A Kenyon; N J Binkin; M Steinman; F Montsho; M Kesupile-Reed; C Hirschfeldt; M Notha; T Moeti; J W Tappero
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis.

Authors:  E Girardi; M C Raviglione; G Antonucci; P Godfrey-Faussett; G Ippolito
Journal:  AIDS       Date:  2000       Impact factor: 4.177

3.  Classification of drug-resistant tuberculosis in an epidemic area.

Authors:  A Van Rie; R Warren; M Richardson; R P Gie; D A Enarson; N Beyers; P D Van Helden
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

4.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; J P Libonati; G Middlebrook
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

5.  Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV.

Authors:  J Bruchfeld; G Aderaye; I B Palme; B Bjorvatn; G Källenius; L Lindquist
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.184

6.  Genetic diversity of Mycobacterium africanum clinical isolates based on IS6110-restriction fragment length polymorphism analysis, spoligotyping, and variable number of tandem DNA repeats.

Authors:  C Viana-Niero; C Gutierrez; C Sola; I Filliol; F Boulahbal; V Vincent; N Rastogi
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Spread of drug-resistant pulmonary tuberculosis in Estonia.

Authors:  A Krüüner; S E Hoffner; H Sillastu; M Danilovits; K Levina; S B Svenson; S Ghebremichael; T Koivula; G Källenius
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  Tuberculosis control and molecular epidemiology in a South African gold-mining community.

Authors:  P Godfrey-Faussett; P Sonnenberg; S C Shearer; M C Bruce; C Mee; L Morris; J Murray
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

9.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

Authors:  C Dye; S Scheele; P Dolin; V Pathania; M C Raviglione
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

Review 10.  Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements.

Authors:  D Van Soolingen
Journal:  J Intern Med       Date:  2001-01       Impact factor: 8.989

View more
  37 in total

1.  Molecular characterization and drug resistance testing of Mycobacterium tuberculosis isolates from Chad.

Authors:  Colette Diguimbaye; Markus Hilty; Richard Ngandolo; Hassane H Mahamat; Gaby E Pfyffer; Franca Baggi; Marcel Tanner; Esther Schelling; Jakob Zinsstag
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  Modern lineages of Mycobacterium tuberculosis in Addis Ababa, Ethiopia: implications for the tuberculosis control programe.

Authors:  A Mihret; Y Bekele; M Aytenew; Y Assefa; M Abebe; L Wassie; G A Loxton; L Yamuah; A Aseffa; G Walzl; R Howe
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

3.  Active tuberculosis case finding and detection of drug resistance among HIV-infected patients: A cross-sectional study in a TB endemic area, Gondar, Northwest Ethiopia.

Authors:  Martha Alemayehu; Baye Gelaw; Ebba Abate; Liya Wassie; Yeshambel Belyhun; Shiferaw Bekele; Russell R Kempker; Henry M Blumberg; Abraham Aseffa
Journal:  Int J Mycobacteriol       Date:  2014-03-24

4.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

5.  First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance.

Authors:  Rocio Lopez-Alvarez; Claudia Badillo-Lopez; Jorge F Cerna-Cortes; Ivan Castillo-Ramirez; Sandra Rivera-Gutierrez; Addy C Helguera-Repetto; Diana Aguilar; Rogelio Hernandez-Pando; Sofia Samper; Jorge A Gonzalez-y-Merchand
Journal:  BMC Microbiol       Date:  2010-03-17       Impact factor: 3.605

6.  Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia.

Authors:  Chanda Mulenga; Isdore C Shamputa; David Mwakazanga; Nathan Kapata; Françoise Portaels; Leen Rigouts
Journal:  BMC Infect Dis       Date:  2010-06-17       Impact factor: 3.090

7.  Polymorphic exact tandem repeat A (PETRA): a newly defined lineage of mycobacterium tuberculosis in israel originating predominantly in Sub-Saharan Africa.

Authors:  Paul J Freidlin; Drora Goldblatt; Hasia Kaidar-Shwartz; Efrat Rorman
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

8.  Underreported threat of multidrug-resistant tuberculosis in Africa.

Authors:  Yanis Ben Amor; Bennett Nemser; Angad Singh; Alyssa Sankin; Neil Schluger
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

9.  Epidemiology of anti-tuberculosis drug resistance patterns and trends in tuberculosis referral hospital in Addis Ababa, Ethiopia.

Authors:  Dereje Abate; Bineyam Taye; Mohammed Abseno; Sibhatu Biadgilign
Journal:  BMC Res Notes       Date:  2012-08-28

10.  Bayesian estimation of mixture models with prespecified elements to compare drug resistance in treatment-naïve and experienced tuberculosis cases.

Authors:  Alane Izu; Ted Cohen; Victor Degruttola
Journal:  PLoS Comput Biol       Date:  2013-03-21       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.